Michael Bloch, MD
Emergency Medicine · New Haven, CTNPI 1669518734
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,660 of the $5,198 with a category attached, or 89.7%. Teva Pharmaceuticals USA, Inc. accounts for 99.6% of it on its own, with 1 other manufacturer making up the rest. Among emergency medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 4 payments — averaging $1299.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$5K
- CSL Behring$23
Across 76 payments — averaging $10,061 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$765K
What the payments were for
- Consulting fees$4,66090%
- Travel & lodging$3246%
- Food & beverage$2144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $5,174 |
| CSL Behring | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$5,174
How this compares
$5,198 in reported general payments places this provider in the 95th percentile of 700 emergency medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 53 | $637 |
| Ondansetron OdtOndansetron | 12 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $78 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $72 |
| Cyclobenzaprine Hcl | 18 | $67 |
| Tramadol Hcl | 16 | $28 |
| Prednisone | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in New Haven
- Thomas RobeyNew Haven$20K
- Rachel LiuNew Haven$14K
- Elias JaffaNew Haven$14K
- Rohit SangalNew Haven$11K
- Andrew KamilarisNew Haven$9K
- Andrew OhNew Haven$3K
- Michelle PerezNew Haven$3K
- Rebekah HeckmannNew Haven$2K
- Gregory LarkinNew Haven$2K
- Meghan HerbstNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.